High frequency of mutations at codon 83 of the gyrA gene of quinolone-resistant clinical isolates of Escherichia coli.

PubWeight™: 0.95‹?› | Rank: Top 15%

🔗 View Article (PMID 8591951)

Published in J Antimicrob Chemother on October 01, 1995

Authors

J Ruiz, F Marco, P Goñi, F Gallardo, J Mensa, A Trilla, T Jimenez de Anta, J Vila

Articles by these authors

Mechanisms of fatty acid-induced inhibition of glucose uptake. J Clin Invest (1994) 5.12

Association of Escherichia coli HEp-2 adherence patterns with type and duration of diarrhoea. Lancet (1991) 4.52

Pathogenic significance of methicillin resistance for patients with Staphylococcus aureus bacteremia. Clin Infect Dis (2000) 3.02

In vitro activity of two echinocandin derivatives, LY303366 and MK-0991 (L-743,792), against clinical isolates of Aspergillus, Fusarium, Rhizopus, and other filamentous fungi. Diagn Microbiol Infect Dis (1998) 2.96

Detection of mutations in parC in quinolone-resistant clinical isolates of Escherichia coli. Antimicrob Agents Chemother (1996) 2.91

Association between double mutation in gyrA gene of ciprofloxacin-resistant clinical isolates of Escherichia coli and MICs. Antimicrob Agents Chemother (1994) 2.87

Bacterial translocation of enteric organisms in patients with cirrhosis. J Hepatol (2001) 2.73

Activation of the oncogenic potential of the avian cellular src protein by specific structural alteration of the carboxy terminus. EMBO J (1987) 2.67

Necrosis of the femoral head after fixation of trochanteric fractures with Gamma Locking Nail. A cause of late mechanical failure. Injury (2003) 2.64

Mesoscale vertical motion and the size structure of phytoplankton in the ocean. Nature (2001) 2.60

Etiology of community-acquired pneumonia: impact of age, comorbidity, and severity. Am J Respir Crit Care Med (1999) 2.55

Invisible mycosis fungoides: A diagnostic challenge. J Am Acad Dermatol (2000) 2.52

Meningococcal disease in a large urban population (Barcelona, 1987-1992): predictors of dismal prognosis. Barcelona Meningococcal Disease Surveillance Group. Arch Intern Med (1999) 2.40

In vitro antimicrobial production of beta-lactamases, aminoglycoside-modifying enzymes, and chloramphenicol acetyltransferase by and susceptibility of clinical isolates of Acinetobacter baumannii. Antimicrob Agents Chemother (1993) 2.34

Effect of grapefruit juice on blood cyclosporin concentration. Lancet (1995) 2.33

Epidemiology and outcome of Pseudomonas aeruginosa bacteremia, with special emphasis on the influence of antibiotic treatment. Analysis of 189 episodes. Arch Intern Med (1996) 2.22

Mutation in the gyrA gene of quinolone-resistant clinical isolates of Acinetobacter baumannii. Antimicrob Agents Chemother (1995) 2.19

[Estimation of the sample size in clinical and epidemiological investigations]. Med Clin (Barc) (1998) 2.18

Paraoxonase2 polymorphisms are associated with nephropathy in Type II diabetes. Diabetologia (2001) 2.18

Impact of invasive and noninvasive quantitative culture sampling on outcome of ventilator-associated pneumonia: a pilot study. Am J Respir Crit Care Med (1998) 2.17

Prognostic factors in meningococcal disease. Development of a bedside predictive model and scoring system. Barcelona Meningococcal Disease Surveillance Group. JAMA (1997) 2.13

Typing and characterization of mechanisms of resistance of Shigella spp. isolated from feces of children under 5 years of age from Ifakara, Tanzania. J Clin Microbiol (1999) 2.11

Bacterial infection in chronic obstructive pulmonary disease. A study of stable and exacerbated outpatients using the protected specimen brush. Am J Respir Crit Care Med (1995) 2.08

High prevalence of cardiovascular risk factors in Gerona, Spain, a province with low myocardial infarction incidence. REGICOR Investigators. J Epidemiol Community Health (1998) 2.08

Salmonella enterica serovar virchow with CTX-M-like beta-lactamase in Spain. J Clin Microbiol (2000) 2.04

[Antimicrobial therapy in exacerbated chronic obstructive pulmonary disease]. Arch Bronconeumol (2002) 2.03

Randomized, comparative study of oral ofloxacin versus intravenous cefotaxime in spontaneous bacterial peritonitis. Gastroenterology (1996) 2.00

Severe community-acquired pneumonia. Assessment of severity criteria. Am J Respir Crit Care Med (1998) 1.99

Quinolone-resistance mutations in the topoisomerase IV parC gene of Acinetobacter baumannii. J Antimicrob Chemother (1997) 1.97

[Assessment of the performance of sabbatical leave: Hospital Clínic i Provincial of Barcelona (1990-1991). Research Committee of the Hospital Clínic i Provincial of Barcelona]. Med Clin (Barc) (1995) 1.96

[Analysis and classification of hospital emergencies through Ambulatory Patient Groups]. Gac Sanit (2003) 1.95

[Cefixime versus amoxicillin plus netilmicin in the treatment of community-acquired non-complicated acute pyelonephritis]. Med Clin (Barc) (1998) 1.95

Partial splenic embolization for the treatment of hypersplenism in cirrhosis. Hepatology (1993) 1.95

Risk factors for lower airway bacterial colonization in chronic bronchitis. Eur Respir J (1999) 1.93

[Minimal intervention in smoking in the outpatient pneumonology consultation]. Arch Bronconeumol (1994) 1.91

Nucleotide sequence of a 13.9 kb segment of the 90 kb virulence plasmid of Salmonella typhimurium: the presence of fimbrial biosynthetic genes. Mol Microbiol (1993) 1.89

Genetic variation in the beta 3-adrenergic receptor and an increased capacity to gain weight in patients with morbid obesity. N Engl J Med (1995) 1.88

Evidence for a circadian rhythm of insulin secretion. Am J Physiol (1996) 1.86

Severe community-acquired pneumonia. Risk factors and follow-up epidemiology. Am J Respir Crit Care Med (1999) 1.83

Pathological and virological findings in patients with persistent hypertransaminasaemia of unknown aetiology. Gut (2000) 1.82

Idiopathic stabbing headache (jabs and jolts syndrome) Cephalalgia (1996) 1.82

Community-acquired pneumonia in the elderly: A multivariate analysis of risk and prognostic factors. Am J Respir Crit Care Med (1996) 1.80

The use of evidence in pharmacovigilance. Case reports as the reference source for drug withdrawals. Eur J Clin Pharmacol (2001) 1.79

European multicentre evaluation of a commercial system for identification of methicillin-resistant Staphylococcus aureus. Eur J Clin Microbiol Infect Dis (1996) 1.79

Biofilm formation in Acinetobacter baumannii: associated features and clinical implications. Clin Microbiol Infect (2008) 1.73

Prevalence of symptomatic and asymptomatic peripheral arterial disease and the value of the ankle-brachial index to stratify cardiovascular risk. Eur J Vasc Endovasc Surg (2009) 1.72

Diarrhea in children under 5 years of age from Ifakara, Tanzania: a case-control study. J Clin Microbiol (2000) 1.72

Paraoxonase polymorphism Met-Leu54 is associated with modified serum concentrations of the enzyme. A possible link between the paraoxonase gene and increased risk of cardiovascular disease in diabetes. J Clin Invest (1997) 1.71

Digestive anisakiasis: clinical manifestations and diagnosis according to localization. Rev Esp Enferm Dig (2002) 1.70

New rapid antigen test for diagnosis of pneumococcal meningitis. Lancet (2001) 1.70

Validation of predictive rules and indices of severity for community acquired pneumonia. Thorax (2004) 1.68

Staphylococcus lugdunensis infective endocarditis: description of 10 cases and analysis of native valve, prosthetic valve, and pacemaker lead endocarditis clinical profiles. Heart (2005) 1.65

Prevalence of Shigella enterotoxins 1 and 2 among Shigella strains isolated from patients with traveler's diarrhea. J Clin Microbiol (1999) 1.63

Norfloxacin prevents spontaneous bacterial peritonitis recurrence in cirrhosis: results of a double-blind, placebo-controlled trial. Hepatology (1990) 1.63

Inhibition of localized adhesion of enteropathogenic Escherichia coli to HEp-2 cells by immunoglobulin and oligosaccharide fractions of human colostrum and breast milk. J Infect Dis (1991) 1.60

Dietary patterns and associated lifestyles in preconception, pregnancy and postpartum. Eur J Clin Nutr (2006) 1.58

Biomarkers improve mortality prediction by prognostic scales in community-acquired pneumonia. Thorax (2009) 1.56

Increased resistance to quinolones in Campylobacter jejuni: a genetic analysis of gyrA gene mutations in quinolone-resistant clinical isolates. Microbiol Immunol (1998) 1.53

Derivation and validation of guidelines for stool cultures for enteropathogenic bacteria other than Clostridium difficile in hospitalized adults. JAMA (2001) 1.53

Triflusal vs aspirin for prevention of cerebral infarction: a randomized stroke study. Neurology (2004) 1.52

Epidemiology and prognostic determinants of bacteraemic catheter-acquired urinary tract infection in a single institution from 1991 to 2010. J Infect (2013) 1.49

Cross-reactivity of anti-Mycobacterium gordonae antibodies with the major mitochondrial autoantigens in primary biliary cirrhosis. J Hepatol (1994) 1.49

Incidence and prevalence of the metabolic syndrome in a cohort of naive HIV-infected patients: prospective analysis at 48 weeks of highly active antiretroviral therapy. Int J STD AIDS (2007) 1.48

Analysis of 4758 Escherichia coli bacteraemia episodes: predictive factors for isolation of an antibiotic-resistant strain and their impact on the outcome. J Antimicrob Chemother (2009) 1.47

A prospective double-blind trial of a low molecular weight heparin once daily compared with conventional low-dose heparin three times daily to prevent pulmonary embolism and venous thrombosis in patients with hip fracture. J Trauma (1989) 1.46

Dual phosphorylation and autophosphorylation in mitogen-activated protein (MAP) kinase activation. Biochem J (1993) 1.45

The Early Systemic Prophylaxis of Infection After Stroke study: a randomized clinical trial. Stroke (2005) 1.44

Impact of early central venous catheter removal on outcome in patients with candidaemia. Clin Microbiol Infect (2007) 1.43

Dissemination of an NDM-2-producing Acinetobacter baumannii clone in an Israeli rehabilitation center. Antimicrob Agents Chemother (2011) 1.43

Should patients with acute exacerbation of chronic bronchitis be treated with antibiotics? Advantages of the use of fluoroquinolones. Clin Microbiol Infect (2006) 1.42

Biopsy forceps disinfection technique does not influence Helicobacter pylori culture. Am J Gastroenterol (1998) 1.41

High prevalence of carbapenem-hydrolysing oxacillinases in epidemiologically related and unrelated Acinetobacter baumannii clinical isolates in Spain. Clin Microbiol Infect (2007) 1.40

Rapid urinary antigen test for diagnosis of pneumococcal community-acquired pneumonia in adults. Eur Respir J (2003) 1.40

Risk factors for oxacillin/methicillin resistance in coagulase-negative staphylococci. J Hosp Infect (1997) 1.40

Schinzel-Giedion syndrome: report of two sibs. Am J Med Genet (1995) 1.40

[A day in the hospital of the future]. Enferm Infecc Microbiol Clin (1999) 1.39

Recurrent pulmonary embolism. A prospective study. Chest (1989) 1.39

[The white coat effect in primary care. Analysis of patients with newly diagnosed arterial hypertension]. Med Clin (Barc) (1997) 1.39

Iron status in patients receiving erythropoietin for dialysis-associated anemia. Kidney Int (1989) 1.39